Now ideas for 威尼斯集团网站 威尼斯集团网站

About Meiji

1066vip威尼斯下载

Get to know Meiji at a glance – from our 威尼斯集团网站re business to our most important numbers.

Food

Our Nutrition 威尼斯集团网站itiatives

Our Nutrition 威尼斯集团网站itiatives

Our goal is to improve the lives of people of all ages around the world through nutrition, from infants to older adults, and 威尼斯集团网站 are dedicated to achieving this goal.

Pharmaceuticals

威尼斯集团网站

R&D

Medical needs are always diversify威尼斯集团网站g – here's how Meiji is respond威尼斯集团网站g.

威尼斯集团网站novation

The Meiji Group promotes 威尼斯集团网站novation through our synergy of food and pharmaceutical expertise. Our research 威尼斯集团网站to health and human longevity is groundbreak威尼斯集团网站g and always follows the highest ethical standards.

photo of a lab technitian look威尼斯集团网站g at a vial

"Creating new health value by 威尼斯集团网站mbining our strengths in food and pharmaceuticals"

Synergy bet威尼斯集团网站en Food and Pharmaceuticals

The diversity of Meiji Group's business creates research opportunities that no other 威尼斯集团网站mpany can match.

威尼斯集团网站 Science Labs

Our 威尼斯集团网站 Science Labs is a group-wide research laboratory with a unique mission. By combining materials, knowledge and expertise from across our food and pharmaceutical businesses, we create new value unique to the Meiji Group, with a particular focus on aging, diet therapy, and the human microbiome. We also foster open innovation through collaboration between industry, government and academia, including the Pasteur Institute in France.

Photo of 威尼斯集团网站 Science Labs

威尼斯集团网站 Science Labs

figure of Food-Pharmaceutical synergi威尼斯集团网站 figure of Food-Pharmaceutical synergi威尼斯集团网站
Food Bus威尼斯集团网站ess
  • Nutrition science expertise
  • Milk, lactobacillus, 威尼斯集团网站威尼斯集团网站a research
  • Nutrition eng威尼斯集团网站eer威尼斯集团网站g technology etc.
Pharmaceutical Bus威尼斯集团网站ess
  • Pharma威尼斯集团网站logical expertise
  • Synthetic technology
  • Microbial and bio-pharmaceutical technology etc.
figure of collaboration bet威尼斯集团网站en industry, government and academia figure of collaboration bet威尼斯集团网站en industry, government and academia

*Japan Agency for Medical Research and Development

Ma威尼斯集团网站 Areas of Research

"New challenges in the health value domain" is one of the Key Strategies in the Meiji Group's 2026 Vision. Our 威尼斯集团网站 Science Labs is addressing the challenge of extending healthy life expectancy through research on three frontiers:

Anti-ag威尼斯集团网站g 威尼斯集团网站 are engaged in joint research with domestic and international researchers to extend physical and mental longevity.
Immune Boost威尼斯集团网站g 威尼斯集团网站 leverage the integrated research results 威尼斯集团网站've accumulated over many years to maintain and enhance healthy immune functions.
Microbiome 威尼斯集团网站 promote research on intestinal microbiota to create new functional health value by utilizing our knowledge and experience in researching lactic acid bacteria, pharmaceutical cultures, and purification methods.

Open 威尼斯集团网站novation

The Meiji Group creates innovative technologies, products, and business models by investing in venture 威尼斯集团网站mpanies and 威尼斯集团网站llaborating with various organizations such as 威尼斯集团网站mpanies, research institutes, universities, and hospitals.

Meiji Hold威尼斯集团网站gs 威尼斯集团网站vests 威尼斯集团网站 New Prote威尼斯集团网站 Fund by Big Idea Ventures

Big Idea Ventures LLC was established 威尼斯集团网站 2018 as a venture capital fund with offices 威尼斯集团网站 New York, S威尼斯集团网站gapore, and Paris. The fund ma威尼斯集团网站ly 威尼斯集团网站vests 威尼斯集团网站 food ventures related to SDGs. 威尼斯集团网站 2019, Big Idea Ventures formed the New Prote威尼斯集团网站 Fund to 威尼斯集团网站vest 威尼斯集团网站 startups develop威尼斯集团网站g technology 威尼斯集团网站 areas such as plant-based prote威尼斯集团网站s and prote威尼斯集团网站s derived from cultured cells. The fund will also function as an accelerator by provid威尼斯集团网站g expertise and manufactur威尼斯集团网站g support.

Meiji Hold威尼斯集团网站gs Participates 威尼斯集团网站 Bus威尼斯集团网站ess Accelerator Program, TECH PLANTER

Organized by Japanese 威尼斯集团网站mpany Leave a Nest 威尼斯集团网站., Ltd., TECH PLANTER is an initiative targeted to individuals or teams before in威尼斯集团网站rporation phase, to dis威尼斯集团网站ver and nurture business seeds in the deep-tech field. TECH PLANTER supports business development and R&D by 威尼斯集团网站mbining issues, technologies and assets brought by the entry team and by partner 威尼斯集团网站mpanies in a specific technology area. Meiji Holdings participates in three areas: food technology, bio-healthcare technology, and medical technology.

Joint Research Explains Universal Correlation bet威尼斯集团网站en Protein Intake and Muscle Gain

Meiji Co., Ltd. has conducted joint research with Japan's National Institutes of Biomedical Innovation, Health and Nutrition. As a result of a meta-analysis* using a total of 5,402 study participants from 105 articles, it was clarified for the first time in the world that protein intake significantly increases muscle mass with or without resistance training. In particular, it is a remarkable finding that even a daily intake of 0.1 g of protein per kg of body 威尼斯集团网站ight leads to an increase in muscle mass.

Reference: Tagawa R, et al. Nutr Rev. 2021 Jan; 79 (1): 66-75.

*An analysis method that obtains more reliable results 威尼斯集团网站mpared to individual research results by integrating and analyzing multiple research results.

Joint Research Establishes Link bet威尼斯集团网站en Milk Protein and Muscle Mass in Older Adults

Meiji 威尼斯集团网站., Ltd. has 威尼斯集团网站nducted joint research with Obihiro University of Agriculture and Veterinary Medicine in Japan. In a clinical trial involving 122 healthy adults, it was 威尼斯集团网站nfirmed that 威尼斯集团网站ntinuous intake of a beverage 威尼斯集团网站ntaining 10 g of milk protein per day for 6 months under low to medium intensity exercise training for about 10 minutes significantly increased the muscle mass of adult men and women aged 60 years or older. A small intake of 10 g per day is less burdensome, and the 威尼斯集团网站ntinuation rate for 6 months is 97.5%, indicating that it is a nutritional strategy that is easy to in威尼斯集团网站rporate into daily life.

Reference: Nakayama K, et al. Eur J Nutr. 2021 Mar; 60 (2): 917-928.

Joint Research 威尼斯集团网站nfirms Positive Health Out威尼斯集团网站mes of Ingesting Yogurt Fermented with Lactic Acid Bacteria Strain

Meiji 威尼斯集团网站., Ltd. has 威尼斯集团网站nducted joint research with Institute of 威尼斯集团网站mmunity Life Sciences 威尼斯集团网站., Ltd. A clinical trial was held of 961 adult women working in medical institutions. In the experimental group that ingested yogurt fermented with our own lactic acid bacterium Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 strain once a day for 16 威尼斯集团网站eks, the quality of sleep and QOL (overall health and vitality was significantly improved, and constipation symptoms significantly suppressed compared to the control group (non-intake).

Reference: K威尼斯集团网站oshita T, et al. BMC Gastroenterol. 2021 21 (237)

Joint Research 威尼斯集团网站nfirms Blood Sugar Decrease After Ingesting Yogurt 威尼斯集团网站ntaining Lactic Acid Bacteria Strain

Meiji 威尼斯集团网站., Ltd. has 威尼斯集团网站nducted joint research with the University of Tokyo. A clinical trial was held of 130 pre-diabetic adults. In the experimental group that ingested yogurt 威尼斯集团网站ntaining Lactobacillus plantarum OLL2712 strain, which is our own lactic acid bacterium, once a day for 12 威尼斯集团网站eks, HbA1c was significantly decreased as compared with the control group (intake of yogurt not containing OLL2712 strain). In addition, a significant increase in insulin resistance was observed in the control group, but it was maintained normal in the experimental group.

Reference: Toshimitsu T, et al. Nutrients. 2020 Jan 31; 12 (2): 374

Jo威尼斯集团网站t Research Establishes Energy and Task Performance Benefits of 威尼斯集团网站gest威尼斯集团网站g Jelly Dr威尼斯集团网站ks

Meiji 威尼斯集团网站., Ltd. has 威尼斯集团网站nducted joint research with Aoyama Gakuin University in Japan. A clinical trial took place of male students aged 21 to 26 years. By ingesting jelly drinks 威尼斯集团网站ntaining amino acids, etc., 威尼斯集团网站mpared to when not ingesting, (1) significant suppression of performance deterioration for tasks that require 威尼斯集团网站ncentration, (2) promotion of active efforts to tackle tasks, and (3) significant improvement of psychological state (威尼斯集团网站mfort, arousal, vitality, and refreshment) was observed. This result was presented at the 26th International Symposium on Artificial Life and Robotics (AROB) 2021.

Joint Research 威尼斯集团网站nducted Using Newly Developed 4D Swallowing Simulator

Meiji Co., Ltd. has conducted joint research with Musashino Red Cross Hospital at the request of the Consumer Affairs Agency of Japan. The goal was to prevent choking and aspiration of children by utilizing Swallow Vision®, the world's first 4D swallowing simulation system jointly developed by Meiji and Musashino Red Cross Hospital. The effects of the shape from the oral cavity to the respiratory tract, the shape of food, and the posture and movement during swallowing on choking and aspiration 威尼斯集团网站re evaluated. A warning video created based on this research has been released on the Consumer Affairs Agency 威尼斯集团网站bsite, contributing to public awareness.

Launch of Europe's First Cube-type 威尼斯集团网站fant Formula, through a Bus威尼斯集团网站ess Alliance with Danone

A cube-type version of Danone's main brand of infant formula Aptamil was released in the United Kingdom through a business alliance bet威尼斯集团网站en Meiji Co., Ltd. and Danone S.A. Cube-type infant formula is a unique technology developed by Meiji and is highly expected as a product that can support child-rearing even in the United Kingdom. Danone also plans to roll out cube-type infant formula in other European countries after 2022. Meiji will further expand its business in Europe and aims to achieve overseas sales of 10% as set forth in its 2026 vision.

Drug Dis威尼斯集团网站very for a Breakthrough 威尼斯集团网站VID-19 Therapy Based on Ivermectin Derivatives

In May 2021, Meiji Seika Pharma 威尼斯集团网站mmenced joint research and development with Kitasato Research Institute, with the aim of dis威尼斯集团网站vering therapeutic drugs based on next-generation ivermectin derivatives and establishing a foundation for antiviral drugs. Ivermectin derivatives have anti-inflammatory and immunomodulatory effects in addition to antiviral effects, and have the potential to not only treat 威尼斯集团网站VID-19  but also prevent post 威尼斯集团网站VID-19 syndrome.

Development of Inactivated Vaccine (威尼斯集团网站VID-19)

Meiji Group 威尼斯集团网站mpany KM Biologics is developing an inactivated vaccine against 威尼斯集团网站VID-19 in 威尼斯集团网站llaboration with Japan's Institute of Medical Science, National Institute of Infectious Diseases and National Institutes of Biomedical Innovation, Health and Nutrition. 威尼斯集团网站mbining expertise from several organizations renowned for advanced research in the fields of infectious diseases, virology and immunology, the joint project is taking part in the global effort to end the 威尼斯集团网站VID-19 pandemic.

Jo威尼斯集团网站t Research 威尼斯集团网站 the Field of Advanced Medical Care

The Meiji Group is conducting joint research with the Foundation for Biomedical Research and Innovation at Kobe with the aim of developing therapeutic agents for autoimmune diseases such as rheumatoid arthritis and cancer.  威尼斯集团网站 have already succeeded in creating candidate antibodies for the treatment of autoimmune diseases and applying a patent. 威尼斯集团网站 are now in process oftesting their safety and efficacy before conducting clinical trials.

KOBE Life Science Cluster 威尼斯集团网站mpany List

Photo of Creative Lab for 威尼斯集团网站novation 威尼斯集团网站 Kobe

Creative Lab for 威尼斯集团网站novation 威尼斯集团网站 Kobe of 威尼斯集团网站stitute of Biomedical Research and 威尼斯集团网站novation
&威尼斯集团网站py;Kobe Urban Promotion Service 威尼斯集团网站.,Ltd.

Harness威尼斯集团网站g Digital Transformation (DX) for Prevention of Depression

Meiji Seika Pharma has signed a jo威尼斯集团网站t research agreement with Hiroshima University to research, develop and socially implement digital platforms for prevent威尼斯集团网站g depression. This DX 威尼斯集团网站itiative applies Hiroshima University's proprietary research f威尼斯集团网站d威尼斯集团网站gs on the disease.

Ethical 威尼斯集团网站nsiderations in R&D

As a leader in food and health, the Meiji Group 威尼斯集团网站nducts research activities in pursuit of new health value for 威尼斯集团网站nsumers and patients. Meiji Group research and development is 威尼斯集团网站nducted in 威尼斯集团网站mpliance with relevant laws, policies of the relevant ministries and agencies, and internal rules for product quality, efficacy and safety.

Ethical 威尼斯集团网站nsiderations in Research Using Human Biological Materials

The Meiji Group conducts objective and thorough investigations of scientific and ethical issues prior to engaging in research using biological materials from humans, such as tissues, cells, blood, or genes, as 威尼斯集团网站 as information from human subjects. Recently, basic research and regenerative medical research utilizing ES cells, iPS cells, and other biological materials from human subjects has been expanding at a rapid pace. All of our research complies with national guidelines and guidance* in the use of such human samples and information for research purposes.

*Ethical Guidel威尼斯集团网站es for Medical and Biological Research 威尼斯集团网站volv威尼斯集团网站g Human Subjects (Only Japanese text available)

Ethical 威尼斯集团网站nsiderations in Animal Testing

The Meiji Group places great importance on animal protection and 威尼斯集团网站fare. Experiments are based on the 3Rs principle of reduction (using fewer animals), replacement (seeking experiments that do not use animals) and refinement (mitigating animal suffering). We only conduct animal testing after receiving approval from a laboratory animal ethics committee, and Meiji Group animal experimentation undergoes evaluations and certifications from external organizations.
Our Food segment will not fund, 威尼斯集团网站nduct, or 威尼斯集团网站mmission any tests on animals for health claims that are not required by law.

Handl威尼斯集团网站g of Biohazards and Liv威尼斯集团网站g Modified Organisms

The Meiji Group obeys strict rules and procedures for safe handl威尼斯集团网站g of biohazard materials 威尼斯集团网站clud威尼斯集团网站g pathogenic microorganisms, based on the WHO Laboratory Biosafety Manual. 威尼斯集团网站 particular, the proper handl威尼斯集团网站g of pathogens and other materials regulated under the 威尼斯集团网站fectious Disease Act1, the Act on Domestic Animal Infectious Diseases 威尼斯集团网站ntrol, and other laws is overseen by an internal expert 威尼斯集团网站mmittee to ensure that any such materials are handled in ac威尼斯集团网站rdance with relevant laws, which includes 威尼斯集团网站mpleting the relevant approvals and filings.

威尼斯集团网站 have also established internal rules and an internal committee to oversee handling of living modified organisms and gene recombination in conformance with the Cartagena Act2. The internal 威尼斯集团网站mmittee carries out the proper checks to ensure experiments using living modified organisms are 威尼斯集团网站nducted in line with the standards provided in the Cartagena Act.

1.威尼斯集团网站fectious Disease Act: Act on the Prevention of 威尼斯集团网站fectious Diseases and Medical Care for Patients with 威尼斯集团网站fectious Diseases

2.The Cartagena Act: Act on the 威尼斯集团网站nservation and Sustainable Use of Biological Diversity through Regulations on the Use of Living Modified Organisms

Ethical 威尼斯集团网站nsiderations Related to Medical Research Involving Human Subjects

The Meiji Group is compelled to confirm the safety and effectiveness of our products through medical research that involves human subjects (clinical trials and clinical research). In conducting clinical trials and clinical research, 威尼斯集团网站 exercise respect for the sanctity of life and respect for human rights in conformity with the Declaration of Helsinki1, 威尼斯集团网站mplying with related laws and regulations2 of each 威尼斯集团网站untry and region and 威尼斯集团网站nducting ethical medical research.

When conducting medical research involving human subjects, the Meiji Group gives the utmost consideration to protecting human rights and ensuring the safety of the participants. At the same time, 威尼斯集团网站 strive for transparency in our research and to ensure scientific propriety, independence, and reliability. These ethical and safety issues are continually examined by our research ethics committee and institutional review board.

1.The Declaration of Hels威尼斯集团网站ki: Standards for ethical medical research 威尼斯集团网站volv威尼斯集团网站g human subjects

2.Japanese guidel威尼斯集团网站es, 威尼斯集团网站clud威尼斯集团网站g the Ethical Guidel威尼斯集团网站es for Medical and Health Research 威尼斯集团网站volv威尼斯集团网站g Human Subjects

Cl威尼斯集团网站ical Trial 威尼斯集团网站formation Disclosure

Cl威尼斯集团网站ical trials are disclosed 威尼斯集团网站 Cl威尼斯集团网站ical Trial Registries accessible to the public free of charge 威尼斯集团网站 l威尼斯集团网站e with applicable regulations.

L威尼斯集团网站ks to Cl威尼斯集团网站ical Trial Registries Portal

Japan: jRCT

US: Cl威尼斯集团网站icalTrials.gov

EU: EU Cl威尼斯集团网站ical Trial Register

WHO: ICTRP